KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Amortization of Deferred Charges (2019 - 2025)

GoodRx Holdings' Amortization of Deferred Charges history spans 7 years, with the latest figure at $454000.0 for Q4 2025.

  • For Q4 2025, Amortization of Deferred Charges rose 7.84% year-over-year to $454000.0; the TTM value through Dec 2025 reached $1.8 million, down 29.2%, while the annual FY2025 figure was $1.8 million, 29.2% down from the prior year.
  • Amortization of Deferred Charges for Q4 2025 was $454000.0 at GoodRx Holdings, up from $445000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $864000.0 in Q2 2021 and bottomed at $413000.0 in Q3 2024.
  • The 5-year median for Amortization of Deferred Charges is $846000.0 (2023), against an average of $719052.6.
  • The largest annual shift saw Amortization of Deferred Charges rose 10.22% in 2021 before it tumbled 51.07% in 2024.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $859000.0 in 2021, then decreased by 0.93% to $851000.0 in 2022, then dropped by 0.82% to $844000.0 in 2023, then plummeted by 50.12% to $421000.0 in 2024, then grew by 7.84% to $454000.0 in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Amortization of Deferred Charges are $454000.0 (Q4 2025), $445000.0 (Q3 2025), and $439000.0 (Q2 2025).